The North America Aspiration & Biopsy Needles Market is expected to witness market growth of 4.9% CAGR during the forecast period (2022-2028).
Biopsy needles are medical instruments that are used to execute a biopsy, which is a procedure that involves obtaining a sample of cells from the body for laboratory examination. Fine-needle aspiration and core needle biopsy are two common needle biopsy methods. Needle biopsy is a procedure that takes tissue or fluid samples from muscles, bones, and other organs like the liver and lungs. During the forecast period, increased cancer prevalence and rising healthcare spending are predicted to fuel demand for biopsy needles.
Vacuum-assisted biopsy, image guided biopsy, core needle biopsy, punch biopsy, shave biopsy, excisional biopsy, incisional biopsy, endoscopic biopsy, fine needle aspiration, bone marrow biopsy, and bone marrow aspiration are all examples of biopsies. Surgical and needle biopsies are the two most common types of biopsies. A surgical biopsy involves making an incision in the skin to collect tissue samples, while a core needle biopsy is done in hospitals and imaging centers. This biopsy is done under the guidance of an image. There are numerous advantages of having such biopsies, including the reduced risk of infection or bruising. If the lump turns out to be benign, there will be no need for a surgical biopsy. Although there is a chance that the needle will miss the tumor cells and that this will be misinterpreted as a non-cancerous cell.
Pancreatic cancer research has been adaptive among all cancer studies and research due to the rising occurrence of pancreatic cancer cases. According to a data review conducted by the American Cancer Society in January 2022, cigarette smoking is responsible for nearly 25% of pancreatic cancer cases, overweight accounts for 20%, and inherited genetic syndromes account for 10% of pancreatic cancer cases. Patients suffering from diabetes are at a high risk of developing pancreatic cancer. In 2021, the American Society of Clinical Oncology (ASCO) anticipated that 60,430 adults in the United States (31,950 men and 28,480 women) were diagnosed with pancreatic cancer. The demand for biopsy needles is increasing as the number of incidences of pancreatic cancer rises.
The US Market dominated the North America Aspiration & Biopsy Needles Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $334.6 million by 2028. The Canada Market is anticipated to grow at a CAGR of 7.3% during (2022-2028). Additionally, The Mexico Market is expected to display a CAGR of 6.3% during (2022-2028).
Based on Product Type, the Market is segmented into Biopsy Needles and Aspiration Needles. Based on Procedure, the Market is segmented into Image-guided and Nonimage-guided. Based on Image-guided Type, the Market is segmented into Ultrasound-guided, CT-guided, MRI-guided, Stereotactic, and Others. Based on End User, the Market is segmented into Hospitals & surgical centers, Diagnostic Clinics & pathology laboratories, Ambulatory care centers, Research & Academic Institutes. Based on Application, the Market is segmented into Tumor/ Cancer Applications, Wound Applications, and Others. Based on Tumor/ Cancer Applications Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Johnson & Johnson, Merit Medical Systems, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ConMed Corporation, Olympus Corporation, Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product Type
By Country
Biopsy needles are medical instruments that are used to execute a biopsy, which is a procedure that involves obtaining a sample of cells from the body for laboratory examination. Fine-needle aspiration and core needle biopsy are two common needle biopsy methods. Needle biopsy is a procedure that takes tissue or fluid samples from muscles, bones, and other organs like the liver and lungs. During the forecast period, increased cancer prevalence and rising healthcare spending are predicted to fuel demand for biopsy needles.
Vacuum-assisted biopsy, image guided biopsy, core needle biopsy, punch biopsy, shave biopsy, excisional biopsy, incisional biopsy, endoscopic biopsy, fine needle aspiration, bone marrow biopsy, and bone marrow aspiration are all examples of biopsies. Surgical and needle biopsies are the two most common types of biopsies. A surgical biopsy involves making an incision in the skin to collect tissue samples, while a core needle biopsy is done in hospitals and imaging centers. This biopsy is done under the guidance of an image. There are numerous advantages of having such biopsies, including the reduced risk of infection or bruising. If the lump turns out to be benign, there will be no need for a surgical biopsy. Although there is a chance that the needle will miss the tumor cells and that this will be misinterpreted as a non-cancerous cell.
Pancreatic cancer research has been adaptive among all cancer studies and research due to the rising occurrence of pancreatic cancer cases. According to a data review conducted by the American Cancer Society in January 2022, cigarette smoking is responsible for nearly 25% of pancreatic cancer cases, overweight accounts for 20%, and inherited genetic syndromes account for 10% of pancreatic cancer cases. Patients suffering from diabetes are at a high risk of developing pancreatic cancer. In 2021, the American Society of Clinical Oncology (ASCO) anticipated that 60,430 adults in the United States (31,950 men and 28,480 women) were diagnosed with pancreatic cancer. The demand for biopsy needles is increasing as the number of incidences of pancreatic cancer rises.
The US Market dominated the North America Aspiration & Biopsy Needles Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $334.6 million by 2028. The Canada Market is anticipated to grow at a CAGR of 7.3% during (2022-2028). Additionally, The Mexico Market is expected to display a CAGR of 6.3% during (2022-2028).
Based on Product Type, the Market is segmented into Biopsy Needles and Aspiration Needles. Based on Procedure, the Market is segmented into Image-guided and Nonimage-guided. Based on Image-guided Type, the Market is segmented into Ultrasound-guided, CT-guided, MRI-guided, Stereotactic, and Others. Based on End User, the Market is segmented into Hospitals & surgical centers, Diagnostic Clinics & pathology laboratories, Ambulatory care centers, Research & Academic Institutes. Based on Application, the Market is segmented into Tumor/ Cancer Applications, Wound Applications, and Others. Based on Tumor/ Cancer Applications Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Johnson & Johnson, Merit Medical Systems, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ConMed Corporation, Olympus Corporation, Argon Medical Devices, Inc., and Cook Medical, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Biopsy Needles
- Aspiration Needles
- Image-guided
- Ultrasound-guided
- CT-guided
- MRI-guided
- Stereotactic
- Others
- Nonimage-guided
- Hospitals & surgical centers
- Diagnostic Clinics & pathology laboratories
- Ambulatory care centers
- Research & Academic Institutes
- Tumor/ Cancer Applications
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Kidney Cancer
- Bone & Bone Marrow Cancer
- Others
- Wound Applications
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Medtronic PLC
- Johnson & Johnson
- Merit Medical Systems, Inc.
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- ConMed Corporation
- Olympus Corporation
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Aspiration & Biopsy Needles Market by Product Type
Chapter 4. North America Aspiration & Biopsy Needles Market by Procedure
Chapter 5. North America Aspiration & Biopsy Needles Market by End User
Chapter 6. North America Aspiration & Biopsy Needles Market by Application
Chapter 7. North America Aspiration & Biopsy Needles Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Medtronic PLC
- Johnson & Johnson
- Merit Medical Systems, Inc.
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- ConMed Corporation
- Olympus Corporation
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Methodology
LOADING...